Covid antivirals lose spark as regulatory scrutiny increases
Published
Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments
Full ArticlePublished
Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments
Full Article